Top headlines: Amazon battles regulators, e-way bill generation grows

Business Standard brings you the top headlines on Wednesday

Top headlines of the hour: Cipla gets DCGI nod to import Moderna vaccine, E-way bill generation picks up pace in June, Amazon battles regulators in bid to stay dominant in India

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

India on Tuesday approved a fourth Covid-19 vaccine--Moderna’s mRNA-1273. With this, the government has cleared the path for importing Covid vaccines approved by international regulators, without bridging clinical studies.

Cipla is supporting Moderna with the regulatory approval for import the vaccines to be donated to India, a company spokesperson said. The vaccine developed by Cambridge (Massachusetts)-based